What tests should be ordered to rule out an endocrine cause of hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Tests to Rule Out Endocrine Causes of Hypertension

To rule out endocrine causes of hypertension, a comprehensive panel of tests should be ordered including aldosterone-renin ratio, plasma free metanephrines, late-night salivary cortisol, and thyroid function tests, along with appropriate imaging studies based on clinical suspicion. 1, 2

Initial Laboratory Investigations

  • Serum electrolytes (sodium, potassium) - hypokalemia may suggest primary aldosteronism 1
  • Serum creatinine and estimated glomerular filtration rate (eGFR) to assess renal function 1
  • Fasting blood glucose - to screen for diabetes which may coexist with endocrine hypertension 1
  • Lipid profile - dyslipidemia often accompanies endocrine hypertension 1
  • Urinalysis - to detect proteinuria or hematuria 1
  • 12-lead ECG - to detect left ventricular hypertrophy or arrhythmias 1

Specific Endocrine Tests

Primary Aldosteronism (Most Common Endocrine Cause)

  • Aldosterone-renin ratio (ARR) - primary screening test 1, 2
  • Ensure proper preparation: discontinue interfering medications (if possible), correct hypokalemia, and maintain adequate sodium intake before testing 3, 4
  • If ARR is elevated, proceed with confirmatory testing (saline suppression test, captopril challenge, or fludrocortisone suppression test) 2, 4

Pheochromocytoma/Paraganglioma

  • Plasma free metanephrines or 24-hour urinary fractionated metanephrines and catecholamines 1, 2
  • Testing should be performed while the patient is supine and relaxed for at least 30 minutes 2, 5

Cushing's Syndrome

  • Late-night salivary cortisol or overnight dexamethasone suppression test 1, 2
  • 24-hour urinary free cortisol if clinical suspicion is high 2, 5

Thyroid Dysfunction

  • Thyroid function tests (TSH, free T4) - both hyperthyroidism and hypothyroidism can cause hypertension 2, 3

Hyperparathyroidism

  • Serum calcium and parathyroid hormone (PTH) levels 5, 3

Imaging Studies

  • Adrenal imaging (CT or MRI) - for suspected primary aldosteronism, Cushing's syndrome, or pheochromocytoma 1, 2
  • Renal ultrasound/renal artery duplex - to evaluate renal parenchymal disease or renal artery stenosis 1
  • CT/MR angiography - if renovascular hypertension is suspected 1
  • Echocardiography - to assess for left ventricular hypertrophy and cardiac function 1

Advanced Testing (Based on Initial Results)

  • Adrenal vein sampling - to determine laterality in primary aldosteronism when surgical intervention is considered 2, 4
  • Genetic testing - for suspected familial forms of endocrine hypertension 6, 3
  • MIBG scan or PET imaging - for localization of pheochromocytoma/paraganglioma 2, 5

Clinical Clues That Warrant Endocrine Testing

  • Age of onset <30 years or sudden onset of hypertension in patients >50 years 2, 6
  • Resistant hypertension (requiring >3 medications from different classes) 2, 3
  • Hypokalemia (spontaneous or diuretic-induced) 1, 4
  • Presence of specific symptoms:
    • Muscle weakness, tetany, cramps (primary aldosteronism) 1, 2
    • Episodic sweating, palpitations, headaches (pheochromocytoma) 1, 2
    • Central obesity, facial plethora, purple striae (Cushing's syndrome) 1, 5
    • Enlarged thyroid, tachycardia or bradycardia (thyroid disorders) 2, 3

Common Pitfalls to Avoid

  • Failure to discontinue interfering medications before endocrine testing (particularly antihypertensives for aldosterone testing) 2, 4
  • Not recognizing drug-induced hypertension before extensive workup 2
  • Inadequate preparation for specialized endocrine tests leading to false results 3, 4
  • Overlooking primary aldosteronism due to absence of hypokalemia (present in only 9-37% of cases) 3, 4

Early identification and appropriate management of endocrine hypertension can significantly reduce morbidity and mortality associated with these conditions 6, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach to Secondary Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Endocrine causes of hypertension: literature review and practical approach.

Hypertension research : official journal of the Japanese Society of Hypertension, 2023

Research

Endocrine Hypertension: A Practical Approach.

Advances in experimental medicine and biology, 2017

Research

Approach to Endocrine Hypertension: A Case-Based Discussion.

Current hypertension reports, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.